138 related articles for article (PubMed ID: 15917995)
1. Activation of protein kinase C alpha is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W; Jun-Ming H
J Biomed Sci; 2005; 12(2):289-96. PubMed ID: 15917995
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
3. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
4. Involvement of p-15(INK4b) and p-16(INK4a) gene expression in saikosaponin a and TPA-induced growth inhibition of HepG2 cells.
Wu WS; Hsu HY
Biochem Biophys Res Commun; 2001 Jul; 285(2):183-7. PubMed ID: 11444823
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species mediated sustained activation of protein kinase C alpha and extracellular signal-regulated kinase for migration of human hepatoma cell Hepg2.
Wu WS; Tsai RK; Chang CH; Wang S; Wu JR; Chang YX
Mol Cancer Res; 2006 Oct; 4(10):747-58. PubMed ID: 17050668
[TBL] [Abstract][Full Text] [Related]
6. Phorbol ester-induced low density lipoprotein receptor gene expression in HepG2 cells involves protein kinase C-mediated p42/44 MAP kinase activation.
Kumar A; Chambers TC; Cloud-Heflin BA; Mehta KD
J Lipid Res; 1997 Nov; 38(11):2240-8. PubMed ID: 9392422
[TBL] [Abstract][Full Text] [Related]
7. Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cells.
Fujii T; Nakamura AM; Yokoyama G; Yamaguchi M; Tayama K; Miwa K; Toh U; Kawamura D; Shirouzu K; Yamana H; Kuwano M; Tsuda H
Oncol Rep; 2005 Aug; 14(2):489-94. PubMed ID: 16012735
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cyclin D1 and its signaling components by the phorbol ester TPA and the tyrosine phosphatase inhibitor vanadate.
Yan S; Wenner CE
J Cell Physiol; 2001 Mar; 186(3):338-49. PubMed ID: 11169972
[TBL] [Abstract][Full Text] [Related]
9. Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells.
Tsunobuchi H; Ishisaki A; Imamura T
Biochem Biophys Res Commun; 2004 Apr; 316(3):712-9. PubMed ID: 15033458
[TBL] [Abstract][Full Text] [Related]
10. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
11. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
12. Repression of 5-aminolevulinate synthase gene by the potent tumor promoter, TPA, involves multiple signal transduction pathways.
Guberman AS; Scassa ME; Cánepa ET
Arch Biochem Biophys; 2005 Apr; 436(2):285-96. PubMed ID: 15797241
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2.
Hu CT; Wu JR; Cheng CC; Wang S; Wang HT; Lee MC; Wang LJ; Pan SM; Chang TY; Wu WS
Clin Exp Metastasis; 2011 Dec; 28(8):851-63. PubMed ID: 21842414
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of p21(WAF1/CIP1) leads to morphologic changes and esterase activity in TPA-mediated differentiation of human prostate cancer cell line TSU-Pr1.
Sugibayashi R; Shimizu T; Suzuki T; Yamamoto N; Hamada H; Takeda K
Oncogene; 2001 Mar; 20(10):1220-8. PubMed ID: 11313866
[TBL] [Abstract][Full Text] [Related]
15. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2.
Hu CT; Cheng CC; Pan SM; Wu JR; Wu WS
Cell Signal; 2013 Jun; 25(6):1457-67. PubMed ID: 23524339
[TBL] [Abstract][Full Text] [Related]
16. The role of protein kinase C signaling in activated DRA transcription.
Setterblad N; Onyango I; Pihlgren U; Rask L; Andersson G
J Immunol; 1998 Nov; 161(9):4819-24. PubMed ID: 9794414
[TBL] [Abstract][Full Text] [Related]
17. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway.
Liu JF; Crépin M; Liu JM; Barritault D; Ledoux D
Biochem Biophys Res Commun; 2002 May; 293(4):1174-82. PubMed ID: 12054499
[TBL] [Abstract][Full Text] [Related]
18. On the mechanisms of 12-O-tetradecanoylphorbol-13-acetate-induced growth arrest in pancreatic cancer cells.
Salabat MR; Ding XZ; Flesche JB; Ujiki MB; Robin TP; Talamonti MS; Bell RH; Adrian TE
Pancreas; 2006 Aug; 33(2):148-55. PubMed ID: 16868480
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional factor Snail simultaneously triggers cell cycle arrest and migration of human hepatoma HepG2.
Hu CT; Wu JR; Chang TY; Cheng CC; Wu WS
J Biomed Sci; 2008 May; 15(3):343-55. PubMed ID: 18183498
[TBL] [Abstract][Full Text] [Related]
20. PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.
Chiang CW; Huang Y; Leong KW; Chen LC; Chen HC; Chen SJ; Chou CK
J Biomed Sci; 2010 May; 17(1):35. PubMed ID: 20444294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]